1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Jianfeng Zhou: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma Mitoxantrone Hydrochloride Liposome, Rituximab, Lenalidomide - Diffuse Large B-cell Lymphoma | Phase 2 | Unknown | Jianfeng Zhou | 55 | 2022-10-10 | 2022-10-12 |
Lymphoma, Large B-Cell, Diffuse (1)
Lenalidomide (1) · Rituximab (1)
China (1)